4th Quarter - Report
RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues regarding follow on biologics, HR 5629 Pathway for Biosimilars Act; S 1695 Biologics, Price Competition and Innovation Act of 2007, HR 1956 - provide for approval of similar biological products, HR 5629 - establish a pathway for the licensure of biosimilar biological products, HR 1038 - provide for licensing of comparable and interchangeable biological products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | LD,Chief Counsel,LA Rep.Stupak,LA Rep.Deutsch |
| RODNEY HOPPE | Deputy Press Secretary, Energy and Commerce |
| JEFF MACKINNON | LD and LA Rep. Joe Barton (R-Texas) |
| DOUGLAS R NAPPI | Chief Counsel, Senate Banking Committee |
| WILLIAM D PHILLIPS | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | Min.Counsel,Energy&Comm, Special Assist. DOE |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.